SBUX - earnings beat and they raised guidance to 1.81 - 1.84, but analysts were looking for 1.86 so the stock sells off. 57.4 was a double bottom during after hours, but with this news about Spain bringing the markets down ah's, I'm thinking we see further drops and this wont become a good long until next week. Still long bias off of weakness below 57.4, possibly 57.
246.3 mln, in line with expectations. EPS was
below the Street view of $0.25 per share.
For 2012, the company now expects sales to increase about 14% over 2011, vs.
previous guidance of a 15% increase. EPS is expected to decrease about 9% to 10%
vs. previous expectations of flat. So not good e/r numbers and the stock comes crashing down, expect it to try to run back some, but I'd be looking to play the short after this run up, the 61 level is decent resistance.
$700 million to gain access to the private
company's enzyme treatment for a kind of cancer. 50.90 to 51.49 was resistance after hours and since the volume that pop'd it was super light then I'd be short out of the gate for a trade. Good resistance at 53 as well.
ANR - reverse head and shoulders pattern, buy <16's for the swing.
LCC - good resistance at 10.45, look to short off this level.
FRIDAY, April 27
Extended-Hours Earnings: AAN, AXL, ABFS, B, CPN, CVX, CVH, COV, DTE, HELE,
IMGN, IP, KKR, LPNT, MRK, NWL, PG, GT, WY, VFC, ZBRA.
Economic Data: 8:30 a.m. GDP; Employment Cost Index;
9:55 a.m. Michigan Sentiment.